Tools for
what happens
next.
Acta Labs is a health technology product lab building practical tools for moments when people need a clearer path through healthcare: after a result, after a decision, after a risk signal, or before care.
ActOn portfolio
ActOn portfolio
The ActOn portfolio is a set of public-benefit health technology projects in development.
Each project addresses a gap between information and action: from result to resolution, decision to access, and symptom burden to care.
ActOnDx
From result to resolution
ActOnDx is a follow-up management concept for abnormal and high-risk diagnostic results. It is designed to help healthcare teams track responsibility, patient contact, next steps, appointments, escalation, and documented resolution.
Seeking technical, clinical, validation, and strategic partners.
ActOnVax
From decision to access
ActOnVax is a practical tool for people who have decided to get vaccinated. It helps users understand which guidance may apply to them, find where vaccination is available, and determine whether and how it may be paid for.
Exploring public health, pharmacy, payer, agency, and distribution partnerships.
ActOnPain
From pain burden to care
ActOnPain is developing a tool to help people document how pain affects sleep, movement, daily function, treatment, and quality of life before a medical appointment. The project will also explore whether patient-reported burden and wearable data can provide a more useful picture of pain over time than a single pain-intensity score.
Seeking patient, clinical, research, digital health, and wearable technology partners.
Engagement
Ways to work together
Acta Labs works with healthcare organizations, health technology companies, patient groups, foundations, agencies, researchers, and industry partners.
ActOn partnerships
Support, shape, validate, adopt, distribute, license, or advance an existing Acta Labs project.
New product development
Turn an unmet need, patient problem, evidence gap, or workflow failure into a clear product concept, prototype, and implementation plan.
Focused advisory
Bring Acta Labs into a defined project involving product strategy, evidence, claims, pilot design, partnerships, adoption, project review, or a focused workshop.
Acta Labs works with partners that can help fund, validate, distribute, and sustain useful health tools. Some tools may remain freely accessible, while institutions fund development, adaptation, implementation, licensing, or ongoing support.
Practical methods
How we work
Acta Labs uses structured methods to assess readiness, align claims with evidence, and map how health technologies fit into real care settings.
Health Tech Readiness Lab
A structured method for assessing what stage a health technology is in, what evidence exists, what remains uncertain, and what next decision the evidence can support.
Start readiness checkReal-World Translation Canvas
A working canvas for mapping how a health technology could fit into real care settings, workflows, users, and adoption contexts.
Start translation canvasClaims-to-Evidence Map
A tool for aligning product, clinical, operational, and commercial claims with the evidence available now.
Start claims mapYour answers stay in your browser while you use the tools. They are not stored, submitted, or sent to Acta Labs unless you choose to share them.
About
Acta Labs was created by Anastasia Liapis, PhD, a health technology executive with experience across molecular diagnostics, digital health, startup leadership, acquisition, post-acquisition integration, corporate innovation, product strategy, partnerships, and commercialization.
Her work focuses on helping health technologies move from promising science to practical use: clearer positioning, stronger evidence, better workflows, and more credible paths to adoption.
Acta Labs applies that same translation work to public-benefit health technology tools, with a focus on follow-up, access, evidence, workflow, and patient safety.
Contact
If you are working on a diagnostic, AI health tool, digital health product, public-interest health tool, evidence question, or health technology translation problem, I'd be glad to hear from you.